In differentiated thyroid cancer, RET gene fusions account for approximately 6–10% of papillary thyroid cancer (PTC) cases and 6% of poorly differentiated thyroid cancer (PDTC) cases but are rare in anaplastic thyroid cancer (ATC) cases. This evidence concerns the gene RET and thyroid gland papillary carcinoma.